Share

US FDA commissioner to stand down - sources

Washington - Dr Margaret Hamburg, commissioner of the US Food and Drug Administration (FDA), who for almost six years has overseen public health initiatives ranging from tobacco control and food safety to personalised medicine, disease control and drug approvals, is stepping down, according to a person briefed on the matter.

The White House is expected to announce Hamburg's resignation later on Friday, the person said. FDA spokesperson Stephanie Yao declined to comment.

Hamburg, 59, is one of the longest-serving FDA commissioners in the modern era. She was nominated by President Barack Obama and confirmed by the US senate in May 2009 and last year was named the world's 51st most powerful woman by Forbes.

Dr Stephen Ostroff, the FDA's chief scientist, will fill Hamburg's position until a new commissioner is named, said a second person familiar with the matter.

Late last month, the agency named Dr. Robert Califf, a prominent cardiologist and researcher from Duke University, to oversee its drug, medical device and tobacco policy. Califf is viewed by many as a potential successor to Hamburg.

A long-time public health official with extensive experience fighting Aids and tuberculosis, Hamburg, who graduated from Harvard Medical School, previously served at the National Institutes of Health before becoming New York City's health commissioner. She was not available for comment.

Her resignation comes as the FDA prepares for what could be a significant transformation, spurred on the one hand by initiatives in Congress to further speed new drug development, and on the other by food safety advocates, backed by the president, who would like to see the creation of a separate agency combining the food safety functions of the FDA and the US department of agriculture.

More engagement

Under Hamburg's leadership the FDA, which oversees products representing more than 20 cents of every dollar spent by US consumers, has proposed measures to improve nutrition by limiting dangerous trans-fats in food and requiring restaurants to post calorie counts on menus. It has also beefed up inspections of food and drugs from overseas, and increased patient engagement in the drug development process.

The agency has introduced multiple measures to speed the development and review of new drugs. In 2014, the FDA approved 51 new therapies, the most in almost 20 years. In a blog post on Wednesday, Hamburg called the achievement "a testament ... to FDA's innovative approaches to help expedite development and review of medical products that target unmet medical needs."

During her tenure the FDA has confronted major public health issues, including the rise of antibiotic-resistant bacteria, the abuse of opioid painkillers, the emergence of electronic cigarettes and the outbreak of Ebola and other infectious diseases.

Her ride has not always been smooth. She faced hostile questioning by Republicans in Congress following a fungal meningitis outbreak in 2012 that killed dozens and sickened hundreds more. And she has been caught up in some controversial political battles.

In 2011, then Health and Human Services Secretary Kathleen Sebelius overruled the FDA's decision to allow an emergency contraceptive known as Plan B to be sold over the counter to young teenagers. Hamburg insisted Plan B was safe for use, and it was eventually approved two years later.

Hamburg was never a crusading commissioner in the way of one of her predecessors, Dr David Kessler, who fought to bring tobacco under FDA regulation. But she has made her mark on multiple issues, including the use of targeted therapy to tailor medicines to an individual's genetic makeup. The FDA gained regulatory authority over tobacco products for the first time on her watch, in 2009.

Hamburg comes from a distinguished medical family. Her mother was the first African-American woman to attend Vassar College and to earn a degree from Yale University School of Medicine.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
18.97
-0.3%
Rand - Pound
23.99
-0.4%
Rand - Euro
20.51
-0.2%
Rand - Aus dollar
12.36
-0.0%
Rand - Yen
0.13
-0.4%
Platinum
906.75
+1.1%
Palladium
1,015.63
+1.4%
Gold
2,209.38
+0.7%
Silver
24.63
-0.1%
Brent Crude
86.09
-0.2%
Top 40
68,240
+0.8%
All Share
74,437
+0.7%
Resource 10
57,023
+2.5%
Industrial 25
103,861
+0.6%
Financial 15
16,492
-0.2%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders